Report copyright - CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION … · SUBJECT: Approval recommendation of NDA 22512 (dabigatran etexilate) at a dose of 150 mg BID to decrease the risk of strokes
Please pass captcha verification before submit form